Compounding pharmacist loses right to compound


A NSW pharmacist who was found guilty of unsatisfactory professional conduct and professional misconduct has had his compounding rights severely restricted

Back in April 2016, Mr Nicholas Bova was found guilty of unsatisfactory professional conduct for dispensing medicine that was a potentially unsafe substitution and in excessive amounts.

The medicine in question was Dextran T(500) for use in the human eye, which Mr Bova had substituted with Dextran T(500) Sulphate without checking it was safe for use in the eye, and in a supply of 10 bottles for a single patient.

He was also found guilty of professional misconduct for having dispensed oxytocin without valid prescriptions, and testosterone before date of supply on several occasions.

In addition, the NSW Civil and Administrative Tribunal found he had failed to maintain a drug register for drugs of addiction including codeine and dexamphetamine at his pharmacy, the Bova Compounding Chemist in Caringbah, NSW.

Despite the findings Mr Bova was able to hold onto his registration, although a second decision handed down on 21 February this year outlined restrictive orders on his practice.

Mr Bova has been ordered by the tribunal not to personally compound any pharmaceutical products for human use.

He is also not to allow the bulk extemporaneous compounding of any pharmaceutical product for the purposes of supply for human use.

At his compounding chemist or any pharmacy in which he has majority ownership, Mr Bova is not to allow the compounding of any of the following pharmaceutical products for either human or veterinary use: codeine, dexamphetamine, testosterone, ketamine, and oxytocin.

He has also been ordered to undertake an extensive CPD program over a three-year period, and will be subject to audits by the Pharmacy Council of NSW.

Previous Cuts 'a win for common sense'
Next Back pain linked to higher death risk

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.